Abstract P5-18-09: A Phase I Study of MM-302, a HER2-targeted Liposomal Doxorubicin, in Patients with Advanced, HER2- Positive Breast Cancer

标题
Abstract P5-18-09: A Phase I Study of MM-302, a HER2-targeted Liposomal Doxorubicin, in Patients with Advanced, HER2- Positive Breast Cancer
作者
关键词
-
出版物
CANCER RESEARCH
Volume 72, Issue 24 Supplement, Pages P5-18-09-P5-18-09
出版商
American Association for Cancer Research (AACR)
发表日期
2014-08-15
DOI
10.1158/0008-5472.sabcs12-p5-18-09

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search